Tango Therapeutics prices upsized USD 600 million follow-on stock offering at USD 30 a share

Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

TNGX

0.00
  • Tango Therapeutics priced an upsized underwritten public offering expected to raise about USD 600 million gross.
  • Deal includes 18,166,667 common shares priced at USD 30 per share.
  • Includes pre-funded warrants to buy up to 1,833,395 shares priced at USD 29.999, with a USD 0.001 exercise price.
  • Closing expected around June 11, 2026, subject to customary conditions.
  • Underwriters hold a 30-day option to buy up to 3,000,009 additional shares at the offering price, less discounts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606092249PRIMZONEFULLFEED9734656) on June 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.